Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Endocrine therapy resistance and next generation sequencing

Prof Matthew Ellis - Washington University, USA
Endocrine therapy resistance and next generation sequencing ( Prof Matthew Ellis - Washington University, USA )
17 May 2012

Molecular characterisation of breast cancer: the mutational landscape

Prof Sam Aparicio - University of British Columbia, Vancouver, Canada
Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )
17 May 2012

New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer

Prof Richard Finn - Universtity of California, Los Angeles, USA
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer ( Prof Richard Finn - Universtity of California, Los Angeles, USA )
17 May 2012

Metabolism in malignant tumors: a new approach for treating breast cancer

Prof Tak Mak - University of Toronto, Canada
Metabolism in malignant tumors: a new approach for treating breast cancer ( Prof Tak Mak - University of Toronto, Canada )
17 May 2012

Criteria required before implementation of whole genome arrays in clinical practice

Prof Daniel Hays - University of Michigan, Ann Arbor, USA
Criteria required before implementation of whole genome arrays in clinical practice ( Prof Daniel Hays - University of Michigan, Ann Arbor, USA )
17 May 2012

Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer

Dr Thomas Bachelot - Centre Leon Berard, Lyon, France
Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer ( Dr Thomas Bachelot - Centre Leon Berard, Lyon, France )
17 May 2012

Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer

Dr Aleix Prat - University of North Carolina, USA
Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer ( Dr Aleix Prat - University of North Carolina, USA )
17 May 2012

Innovation in molecular imaging

Prof Hedvig Hricak – Memorial Sloan-Kettering Cancer Center, USA
Innovation in molecular imaging ( Prof Hedvig Hricak – Memorial Sloan-Kettering Cancer Center, USA )
16 May 2012

Advances in radiation oncology

Prof Guy Storme – University of Brussels, Belgium
Advances in radiation oncology ( Prof Guy Storme – University of Brussels, Belgium )
16 May 2012

EurocanPlatform and the exchange of information

Dr Ged Brady – The Paterson Institute for Cancer Research, Manchester, UK
EurocanPlatform and the exchange of information ( Dr Ged Brady – The Paterson Institute for Cancer Research, Manchester, UK )
16 May 2012

Effects of lifestyle change in cancer patients

Prof Cornelia Ulrich – National Center for Tumor Diseases, Heidelberg, Germany
Effects of lifestyle change in cancer patients ( Prof Cornelia Ulrich – National Center for Tumor Diseases, Heidelberg, Germany )
16 May 2012

Benefits of open European research area

Prof Claudio Lombardo – Organisation of European Cancer Institutes
Benefits of open European research area ( Prof Claudio Lombardo – Organisation of European Cancer Institutes )
16 May 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation